This study is testing Allo-QuadCAR01-T, a new off-the-shelf CAR-T therapy for people with hard-to-treat B-cell cancers. Unlike current CAR-T treatments that us…

Lymphoma Diffuse Large B-cellLeukemia and LymphomaLeukemia Relapse+1 more

~Estimated

~$10 – $8,750

AvenCell Therapeutics, Inc.NCT07284433

A Study of Longitudinal Neurocognitive and Neuroimaging Evaluations for Adult Patients With Lymphoma Receiving CD19 CAR T Cell Therapy

The purpose of this study is to learn about possible changes in cognitive (mental) abilities, such as memory skills and concentration, and in brain anatomy (st…

Lymphoma Receiving CAR-T Therapy

~Estimated

~$10 – $750

Memorial Sloan Kettering Cancer CenterNCT04107285